TY - JOUR
T1 - Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea
AU - Jung, Sook In
AU - Shin, Jong Hee
AU - Choi, Hyun Jung
AU - Ju, Min Young
AU - Kim, Soo Hyun
AU - Lee, Wee Gyo
AU - Park, Yeon Joon
AU - Lee, Kyungwon
PY - 2012/11
Y1 - 2012/11
N2 - The in vitro antifungal susceptibility of 636 Candida bloodstream isolates collected from 15 tertiary hospitals in Korea was determined using the Vitek-2 yeast susceptibility system (bioMérieux, France). Overall susceptibility rates were 98.1%, 95.9%, 99.1%, and 97.3% for amphotericin B, fluconazole, voriconazole, and flucytosine, respectively. The results show that the rates of resistance to 4 antifungal drugs remain low among Candida bloodstream isolates in Korea.
AB - The in vitro antifungal susceptibility of 636 Candida bloodstream isolates collected from 15 tertiary hospitals in Korea was determined using the Vitek-2 yeast susceptibility system (bioMérieux, France). Overall susceptibility rates were 98.1%, 95.9%, 99.1%, and 97.3% for amphotericin B, fluconazole, voriconazole, and flucytosine, respectively. The results show that the rates of resistance to 4 antifungal drugs remain low among Candida bloodstream isolates in Korea.
UR - http://www.scopus.com/inward/record.url?scp=84868556629&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84868556629&partnerID=8YFLogxK
U2 - 10.3343/alm.2012.32.6.426
DO - 10.3343/alm.2012.32.6.426
M3 - Article
C2 - 23130342
AN - SCOPUS:84868556629
SN - 2234-3806
VL - 32
SP - 426
EP - 428
JO - Annals of laboratory medicine
JF - Annals of laboratory medicine
IS - 6
ER -